Perrigo Nasal Spray Recalled for Contaminated Excipient
Perrigo Company PLC is recalling NASAL Maximum Strength Nasal Spray (oxymetazoline HCl 0.05%) due to manufacturing with a contaminated excipient that was itself recalled from the supplier. The recall affects one batch distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a contamination issue with an excipient from a supplier. However, the source text does not report any illnesses, injuries, or hospitalizations related to the contaminated product, and no specific hazard from the excipient is identified, making this a precautionary recall with moderate concern.
Plain-English summary
Perrigo Company PLC is recalling NASAL Maximum Strength Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant with Menthol (1 FL Oz / 30 mL bottles, NDC 41250-989-10), distributed nationwide in the USA.
The recall was initiated because the product was manufactured using a contaminated excipient (inactive ingredient) that had been recalled by the excipient supplier. The recalled batch is 1BK0716 with expiration date 12/31/2022. A total of 144 bottles were affected.
This recall resulted from manufacturing deviations related to current Good Manufacturing Practice (CGMP) requirements. Consumers should stop using the recalled batch and consult their pharmacist or physician with questions.
The recalled product
- Product
- NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- NASAL
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK0716
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NASAL
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Decongestant Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27